908 related articles for article (PubMed ID: 19380702)
1. Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease.
Manners DN; Parchi P; Tonon C; Capellari S; Strammiello R; Testa C; Tani G; Malucelli E; Spagnolo C; Cortelli P; Montagna P; Lodi R; Barbiroli B
Neurology; 2009 Apr; 72(16):1425-31. PubMed ID: 19380702
[TBL] [Abstract][Full Text] [Related]
2. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.
Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I
Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221
[TBL] [Abstract][Full Text] [Related]
3. Sporadic Creutzfeldt-Jakob disease without dementia at onset: clinical features, laboratory tests and sequential diffusion MRI (in an autopsy-proven case).
Pauri F; Amabile G; Fattapposta F; Pierallini A; Bianco F
Neurol Sci; 2004 Oct; 25(4):234-7. PubMed ID: 15549511
[TBL] [Abstract][Full Text] [Related]
4. MRI sequence findings in sporadic Creutzfeldt-Jakob disease.
Tian HJ; Zhang JT; Lang SY; Wang XQ
J Clin Neurosci; 2010 Nov; 17(11):1378-80. PubMed ID: 20727770
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted magnetic resonance imaging in diagnosis of Creutzfeldt-Jakob disease.
Lou X; Ma L; An NY; Cai YQ; Liang Y; Guo XG
Chin Med J (Engl); 2006 Aug; 119(15):1242-7. PubMed ID: 16919182
[TBL] [Abstract][Full Text] [Related]
6. The imaging appearance of Creutzfeldt-Jakob disease caused by the E200K mutation.
Fulbright RK; Kingsley PB; Guo X; Hoffmann C; Kahana E; Chapman JC; Prohovnik I
Magn Reson Imaging; 2006 Nov; 24(9):1121-9. PubMed ID: 17071334
[TBL] [Abstract][Full Text] [Related]
7. Creutzfeldt-Jakob disease.
Iwasaki Y
Neuropathology; 2017 Apr; 37(2):174-188. PubMed ID: 28028861
[TBL] [Abstract][Full Text] [Related]
8. 76-space analysis of grey matter diffusivity: methods and applications.
Liu T; Young G; Huang L; Chen NK; Wong ST
Neuroimage; 2006 May; 31(1):51-65. PubMed ID: 16434215
[TBL] [Abstract][Full Text] [Related]
9. MM2-cortical-type sporadic Creutzfeldt-Jakob disease with early stage cerebral cortical pathology presenting with a rapidly progressive clinical course.
Niimi Y; Iwasaki Y; Umemura T; Tanaka F; Yoshida M; Hashizume Y; Kitamoto T; Hirayama M; Sobue G
Neuropathology; 2008 Dec; 28(6):645-51. PubMed ID: 18410280
[TBL] [Abstract][Full Text] [Related]
10. Mathematical models for the diffusion magnetic resonance signal abnormality in patients with prion diseases.
Figini M; Alexander DC; Redaelli V; Fasano F; Grisoli M; Baselli G; Gambetti P; Tagliavini F; Bizzi A
Neuroimage Clin; 2015; 7():142-54. PubMed ID: 25610776
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
[TBL] [Abstract][Full Text] [Related]
12. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration.
Vrenken H; Pouwels PJ; Geurts JJ; Knol DL; Polman CH; Barkhof F; Castelijns JA
J Magn Reson Imaging; 2006 May; 23(5):628-36. PubMed ID: 16565955
[TBL] [Abstract][Full Text] [Related]
13. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type.
Meissner B; Westner IM; Kallenberg K; Krasnianski A; Bartl M; Varges D; Bösenberg C; Kretzschmar HA; Knauth M; Schulz-Schaeffer WJ; Zerr I
Neurology; 2005 Nov; 65(10):1544-50. PubMed ID: 16221949
[TBL] [Abstract][Full Text] [Related]
14. [Pathologic anatomy of the central nervous system in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease)].
Nedz'ved' MK; Protas II; Lystsova EG; Guzov SA; Mil'kamanovich EK
Arkh Patol; 1985; 47(12):14-20. PubMed ID: 3913407
[TBL] [Abstract][Full Text] [Related]
15. White matter involvement in sporadic Creutzfeldt-Jakob disease.
Caverzasi E; Mandelli ML; DeArmond SJ; Hess CP; Vitali P; Papinutto N; Oehler A; Miller BL; Lobach IV; Bastianello S; Geschwind MD; Henry RG
Brain; 2014 Dec; 137(Pt 12):3339-54. PubMed ID: 25367029
[TBL] [Abstract][Full Text] [Related]
16. Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease.
Paquet C; Bose A; Polivka M; Peoc'h K; Brouland JP; Keohane C; Hugon J; Gray F
J Neuropathol Exp Neurol; 2009 Feb; 68(2):190-8. PubMed ID: 19151623
[TBL] [Abstract][Full Text] [Related]
17. An autopsy case of MM2-cortical + thalamic-type sporadic Creutzfeldt-Jakob disease.
Saito Y; Iwasaki Y; Aiba I; Kitamoto T; Yoshida M; Hashizume Y
Neuropathology; 2011 Oct; 31(5):523-30. PubMed ID: 21175861
[TBL] [Abstract][Full Text] [Related]
18. Early diffusion-weighted MRI predicts regional neuronal damage in generalized status epilepticus in rats treated with diazepam.
Engelhorn T; Weise J; Hammen T; Bluemcke I; Hufnagel A; Doerfler A
Neurosci Lett; 2007 May; 417(3):275-80. PubMed ID: 17367928
[TBL] [Abstract][Full Text] [Related]
19. MM1-type sporadic Creutzfeldt-Jakob disease with 1-month total disease duration and early pathologic indicators.
Iwasaki Y; Kato H; Ando T; Mimuro M; Kitamoto T; Yoshida M
Neuropathology; 2017 Oct; 37(5):420-425. PubMed ID: 28402042
[TBL] [Abstract][Full Text] [Related]
20. [Creutzfeldt-Jakob disease: value of MRI].
Urbach H; Paus S; Tschampa HJ; Keller E; Schild HH
Rofo; 2001 Jun; 173(6):509-14. PubMed ID: 11471291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
